Evaluating the role of neoadjuvant chemotherapy and surgery in stage I TNBC

What to do in patients with early-stage TNBC who have not achieved a pCR?Подробнее

Discover the difference between adjuvant and neoadjuvant chemotherapy for breast cancer patients 🎗️🔬Подробнее

Evaluating the Role of Neoadjuvant Endocrine Therapy in Breast CancerПодробнее

Evaluation of Breast Specimens after Neoadjuvant ChemotherapyПодробнее

Identifying the need for neoadjuvant chemotherapy in stage I breast cancerПодробнее

Embracing neo-adjuvant chemotherapy for better outcomes in triple negative breast cancerПодробнее

Role of Neoadjuvant Platinum-Based Therapy for TNBCПодробнее

No pCR in Patients After Neoadjuvant Chemotherapy in TNBCПодробнее

Neoadjuvant Versus Adjuvant Therapy in TNBCПодробнее

Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant TherapyПодробнее

Triple Negative Breast Cancer: What you need to knowПодробнее

Why Don't We Know More About Triple Negative Breast Cancer? #breastcancerПодробнее

Enhancing triple negative breast cancer treatment with immunotherapy across all settingsПодробнее

The challenges of treating early-stage TNBCПодробнее

Neoadjuvant chemotherapy for breast cancer - Time to rethink. 27Jul22Подробнее

KEYNOTE-522: final OS findings of pembrolizumab and chemotherapy in TNBCПодробнее

Update on Keynote 522, the current standard of care for triple negative breast cancer.Подробнее

Optimal neoadjuvant and adjuvant therapy for patients with early TNBCПодробнее

Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...Подробнее